BiotechTube
Home/Paradise Genomics/Michael T. Falduto, Ph.D.
MT

Michael T. Falduto, Ph.D.

Chief Technology Officer, and Founder

Paradise Genomics

Therapeutic Areas

OncologyPsychiatryPain ManagementGastroenterology

Paradise Genomics Pipeline

DrugIndicationPhase
Gastric Cancer BiomarkersGastric CancerDiscovery
Depression BiomarkersDepressionDiscovery
Fibromyalgia BiomarkersFibromyalgiaDiscovery
Colorectal Cancer BiomarkersColorectal CancerDiscovery

Leadership Team at Paradise Genomics

GM
Gary M. Pusateri, M.D.
Chief Executive Officer, Medical Director, and Founder
SR
Scott R. Magnuson, Ph.D.
President, Chief Scientific Officer, and Founder
View full Paradise Genomics profile